Education
About Us
Working with TipRanks
Follow Us
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.75M | $ 10.90M | $ 9.56M | $ 9.22M | $ 9.33M |
| Gross Profit | $ 14.60M | $ 10.90M | $ 7.46M | $ 7.84M | $ -91.86M |
| Operating Income | $ -745.94M | $ -378.94M | $ -235.60M | $ -178.91M | $ -118.05M |
| EBITDA | $ -680.48M | $ -376.16M | $ -233.50M | $ -177.53M | $ -117.41M |
| Net Income | $ -684.63M | $ -322.30M | $ -212.22M | $ -174.00M | $ -118.01M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.70B | $ 1.50B | $ 595.35M | $ 610.73M | $ 405.54M |
| Total Assets | $ 1.96B | $ 1.56B | $ 628.55M | $ 638.80M | $ 427.58M |
| Total Debt | $ 94.56M | $ 6.80M | $ 9.85M | $ 10.69M | $ 11.73M |
| Net Debt | $ -287.95M | $ -213.07M | $ -175.23M | $ -329.71M | $ -308.72M |
| Total Liabilities | $ 269.45M | $ 138.94M | $ 127.79M | $ 60.73M | $ 46.15M |
| Stockholders' Equity | $ 1.69B | $ 1.42B | $ 500.76M | $ 578.08M | $ 381.43M |
| Cash Flow | |||||
| Free Cash Flow | $ -663.76M | $ -307.94M | $ -123.29M | $ -139.09M | $ -98.55M |
| Operating Cash Flow | $ -650.44M | $ -300.87M | $ -119.06M | $ -136.27M | $ -94.81M |
| Investing Cash Flow | $ -38.03M | $ -854.20M | $ -130.07M | $ -189.96M | $ -82.52M |
| Financing Cash Flow | $ 850.99M | $ 1.19B | $ 93.86M | $ 346.17M | $ 176.32M |